GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a prominent focus in medical studies, largely due to its remarkable impact on treating diseases such as adult-onset diabetes and weight gain. Ongoing research have revealed that more than glucose regulation, GLP-1 drugs offer promise for circulatory well-being and perhap